January 26, 2025 - 07:55

Over 35 years after the initial study that linked the artificial food dye Red 3 to thyroid cancer in rats, the United States is taking significant steps to phase it out from foods and drugs. This decision comes after decades of scrutiny surrounding the safety of synthetic food colorings, particularly Red 3, which has been used in various products, including candies, cosmetics, and pharmaceuticals.
The FDA's move is grounded in a growing body of research that raises alarms about the potential health risks associated with Red 3. While the dye has been deemed safe for consumption in the past, the evidence suggesting its link to cancer has prompted a reevaluation of its use. Health advocates and scientists have long argued for stricter regulations on food additives, and the ban on Red 3 marks a pivotal moment in addressing public health concerns.
As consumers become increasingly aware of the ingredients in their food, the phase-out of Red 3 reflects a broader trend towards transparency and safety in food production. The decision is expected to encourage further scrutiny of other artificial colorings and additives in the food supply.
October 16, 2026 - 10:43
Rethinking the Roots of America's Health Care CrisisHealth policy experts John McDonough and Stuart Butler recently debated the origins of the U.S. medical system`s troubles, asking whether economist Milton Friedman deserves blame for the current...
October 15, 2026 - 17:07
MetroPlusHealth Earns 4-Star Medicare Rating for Second Consecutive YearNew York health plan MetroPlusHealth has announced that its Medicare Advantage offerings have received a 4-star rating from the Centers for Medicare and Medicaid Services for the second year in a...
October 15, 2026 - 07:30
Opting Out of Health Data Sharing Proves Frustrating for PatientsPatients who want to keep their medical records private are discovering that the process is far more complicated than expected. Alex Rosenblat recently described her attempt to stop her health...
October 14, 2026 - 18:18
Tech Money Shifts Toward Health Care as Real Rates Draw AttentionInvestors are watching a notable rotation of technology capital into the health care sector, according to Jeff deGraaf, chairman of Renaissance Macro Research. Speaking during a market segment,...